Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer

Ji Yeon Kim1, Woo Jeong Lee2, Ha Young Park3

  • 1Department of Pathology, Inje University Haeundae Paik Hospital, Busan, Korea.

Abstract

Insights

MicroRNAs (miRNAs) are deregulated in non-small cell lung cancer (NSCLC). This study found miR-1, miR-124, and miR-196a are overexpressed in EGFR T790M-mutated NSCLC resistant to tyrosine kinase inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Aberrant miRNA expression is implicated in various cancers, including non-small cell lung cancer (NSCLC).
  • Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a significant clinical challenge in NSCLC, often associated with the T790M mutation.

Purpose of the Study:

  • To investigate the differential expression of miRNAs in NSCLC with the EGFR T790M mutation.
  • To identify specific miRNAs associated with resistance to EGFR TKIs in NSCLC.

Main Methods:

  • Analysis of miRNA expression profiles in six cases of resected NSCLC harboring the T790M mutation.
  • Comparison of miRNA expression using miRNA polymerase chain reaction (PCR) array profiling between EGFR T790M-mutated and L858R-mutated NSCLC.
  • Validation of differentially expressed miRNAs using quantitative real-time PCR (qRT-PCR).

Main Results:

  • miRNA PCR array profiling identified three miRNAs (miR-1, miR-196a, miR-124) with significantly altered expression (≥4.0-fold change) in the T790M group compared to the L858R group.
  • Validation by qRT-PCR confirmed the overexpression of miR-1, miR-196a, and miR-124 in the T790M-mutated NSCLC.
  • miR-1 and miR-124 showed particularly significant overexpression in the T790M group (p < 0.01).

Conclusions:

  • MiR-1, miR-124, and miR-196a are significantly overexpressed in EGFR T790M-mutated NSCLC.
  • These miRNAs may play a role in the development of resistance to EGFR TKIs in NSCLC.
  • Further investigation into the functional roles of these miRNAs could offer potential therapeutic targets.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K